Two Sigma Advisers LP Acquires 24,500 Shares of Humana Inc. (NYSE:HUM)

Two Sigma Advisers LP increased its holdings in Humana Inc. (NYSE:HUM - Free Report) by 2.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,043,580 shares of the insurance provider's stock after acquiring an additional 24,500 shares during the period. Two Sigma Advisers LP owned about 0.87% of Humana worth $330,544,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Creative Financial Designs Inc. ADV grew its holdings in Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock valued at $27,000 after purchasing an additional 61 shares during the period. CarsonAllaria Wealth Management Ltd. grew its holdings in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider's stock valued at $28,000 after purchasing an additional 39 shares during the period. Atwood & Palmer Inc. bought a new position in Humana during the third quarter valued at $29,000. Ashton Thomas Securities LLC bought a new position in Humana during the third quarter valued at $31,000. Finally, Your Advocates Ltd. LLP grew its holdings in Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock valued at $32,000 after purchasing an additional 45 shares during the period. 92.38% of the stock is owned by institutional investors.

Humana Stock Performance

HUM stock traded down $2.32 on Friday, hitting $280.74. The company had a trading volume of 998,825 shares, compared to its average volume of 1,847,193. The stock has a market cap of $33.80 billion, a price-to-earnings ratio of 25.07, a P/E/G ratio of 2.29 and a beta of 0.53. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock's 50-day simple moving average is $273.44 and its 200 day simple moving average is $327.75. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $488.89.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion for the quarter, compared to analysts' expectations of $28.66 billion. As a group, equities research analysts expect that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.26%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana's payout ratio is 31.36%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. JPMorgan Chase & Co. raised their price target on Humana from $332.00 to $396.00 and gave the stock a "neutral" rating in a report on Wednesday, August 21st. Stephens reaffirmed an "equal weight" rating and issued a $250.00 price target on shares of Humana in a report on Wednesday, October 9th. Barclays raised their price target on Humana from $250.00 to $253.00 and gave the stock an "equal weight" rating in a report on Thursday, October 31st. UBS Group cut their price target on Humana from $380.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, October 4th. Finally, Royal Bank of Canada cut their price target on Humana from $400.00 to $265.00 and set an "outperform" rating for the company in a report on Tuesday, October 8th. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.